Digest Network Come funziona
Network
/
Società
In
Non verificato

Infinitopes

Di cosa scriviamo

BiologiaBiotecnologiaFarmaceuticaOncologiaSanità

6 comunicati stampa

Guarda tutti i comunicati
28/07/2026
Mercato del lavoro
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Infinitopes Expands Scientific Advisory Board with World-Leading Clinician-Scientist Dr Kristen Hege
Fonte
Infinitopes
Emittente
Business Wire
1.00
0
23/07/2026
Industria
Oncologia
Salute
Biotecnologia
Medicina - Varie
Farmaceutica
Infinitopes Doses First Patient With Precision Off-the-Shelf Therapeutic Cancer Vaccine ITOP1
Fonte
Infinitopes
Emittente
Business Wire
1.00
0
12/05/2026
Mercato del lavoro
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Infinitopes Appoints Immuno-Oncology Pioneer Jo Brewer as Chief Scientific Officer (CSO) to Advance Therapeutic Pipeline From Clinical to Commercialisation
Fonte
Infinitopes
Emittente
Business Wire
1.00
0
09/04/2025
Farmaceutica
Sanità
Biologia
Infinitopes Granted Phase I/IIa Clinical Trial Application Approval to Evaluate Precision Vaccine Targeting Early-Stage Oesophageal Cancer
Fonte
Infinitopes
Emittente
PR News Wire
1.00
0
20/03/2025
Farmaceutica
Information Technology
Telecomunicazioni
Sanità
Economia
Management
Organizzazione Aziendale
Biologia
Infinitopes Strengthens Board with Two Biotech Leaders to Advance Precision Immunotherapies into the Clinic
Fonte
Infinitopes
Emittente
PR News Wire
1.00
0
08/11/2024
Farmaceutica
Sanità
Finanza
Scienza
Biologia
Infinitopes to Showcase Breakthroughs on Cancer Vaccine Development at SITC 2024: Insight into a double-blind, Phase I/IIa clinical trial
Fonte
Infinitopes
Emittente
PR News Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0